ArticleVeterinary world2025
Optimizing pregnant mare serum gonadotropin dosage for reproductive efficiency and lamb survival in Dorper × Assaf ewes during the non-breeding season.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Reproductive efficiency during the non-breeding season is a critical factor influencing year-round productivity in sheep farming, particularly in semi-arid environments. Pregnant mare serum gonadotropin (PMSG) is commonly used to induce estrus, yet the optimal dosage that maximizes fertility and lamb growth while minimizing hormonal side effects remains unclear. This study aimed to determine the optimal PMSG dose for enhancing reproductive and growth performance in Dorper × Assaf crossbred ewes under semi-extensive conditions in Palestine. Materials and Methods: A total of 143 non-lactating Dorper × Assaf ewes (aged 2-3 years) were synchronized with intravaginal progestagen sponges for 14 days, followed by intramuscular administration of 400, 500, or 600 international units (IU) of PMSG. Key reproductive traits, estrus response, conception rate, abortion rate, fecundity, and lamb survival, were recorded, alongside lamb birth and weaning weights. Data were analyzed using a one-way analysis of variance and a general linear model incorporating parity, litter size, and sex effects, with significance set at p < 0.05. Results: High conception and lambing rates were observed across all groups. The 400 IU PMSG dose resulted in the lowest abortion rate (2.44%) and highest lamb survival (96.9%), while higher doses (500-600 IU) increased abortion incidence without improving fertility outcomes. Birth weight increased with PMSG level (3.42-3.83 kg), whereas weaning weight peaked at 500 IU (22.18 kg). Litter size and lamb sex significantly affected both birth and weaning weights, with singletons and males being heavier. Conclusion: Administering 400 IU of PMSG provides the optimal balance between reproductive performance, lamb survival, cost-efficiency, and animal welfare. Excessive hormonal stimulation at higher doses offers no additional reproductive benefit and may compromise ewe health. Implementing this moderate, breed-specific hormonal protocol enhances fertility while reducing veterinary intervention and production costs, promoting sustainability and welfare-conscious management. These outcomes directly contribute to sustainable development goals (SDG) 2 - zero hunger and SDG 12 - responsible consumption and production, advancing resilient and ethical small-ruminant farming systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.